|
| Light condition | Overexpressed genes after irradiation | Possible cancers affected |
|
| Blue | BUB1B | Brain and lung cancer |
| ERCC5 | Ovarian cancer |
| FANCD2 | Breast cancer and Fanconi anemia |
| MSR1 | Prostate cancer and Barrett’s esophagus/esophageal adenocarcinoma |
|
| Green | ANTXR2 | Hyaline fibromatosis syndrome and hyalinosis, inherited systemically (its related pathways are infectious disease and uptake and actions of bacterial toxins) |
| BUB1B | Brain and lung cancers |
| DIS3L2 | Perlman syndrome and Wilms’ tumor susceptibility-5 |
| EPCAM | Endometrial cancer, biliary tract cancer, and skin cancer |
| ESCO2 | Roberts syndrome and SC phocomelia syndrome |
| EPHB2 | Prostate cancer/brain cancer susceptibility, somatic and prostate cancer |
| EXT1 | Chondrosarcoma and exostoses, multiple, type 1 |
| FANCD2 | Breast cancer and Fanconi anemia |
| KIT | Endometrial cancer as a gastrointestinal stromal tumor |
| MSR1 | Prostate cancer and Barrett’s esophagus/esophageal adenocarcinoma |
| NF1 | Neurofibromatosis-Noonan syndrome and neurofibromatosis, type 1 |
| RET | Multiple endocrine neoplasia iia and medullary thyroid carcinoma, familial |
| TSC1 | Tuberous sclerosis-1 and lymphangioleiomyomatosis |
|
| Red | BUB1B | Brain and lung cancer |
| DIS3L2 | Perlman syndrome and Wilms’ tumor susceptibility-5 |
| FANCB | Fanconi anemia, complementation group B, and Fanconi anemia, complementation group A |
| FANCD2 | Breast cancer and Fanconi anemia |
| KIT | Endometrial cancer as a gastrointestinal stromal tumor |
| MSR1 | Prostate cancer and Barrett’s esophagus/esophageal adenocarcinoma |
| POLE | FILS syndrome and colorectal cancer 12 |
| POLH | Xeroderma pigmentosum, variant type and POHL-related xeroderma pigmentosum |
| RET | Multiple endocrine neoplasia iia and medullary thyroid carcinoma, familial |
| SUFU | Medulloblastoma and basal cell nevus syndrome |
| TMC8 | Epidermodysplasia verruciformis and superficial mycosis |
|
